Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 – Endo Finance LLC and Guarantors

Summary

This document is a counterpart to a Registration Rights Agreement dated May 6, 2014, related to Endo Finance LLC's 7.25% Senior Notes due 2022. By signing, Aphrodite Women’s Health, LLC and Endo Ventures Cyprus Limited agree to be bound as Guarantors under the terms of the original agreement. The agreement outlines their obligations to support the registration of the notes, ensuring compliance with securities regulations. The obligations are unconditional and irrevocable as of March 20, 2015.

EX-10.245 8 ex10245endorracounterpartr.htm RRA 2022 NOTES Ex. 10.245 Endo RRA Counterpart re 7 25% 2022 Notes March 20 2015
Exhibit 10.245


Counterpart to Registration Rights Agreement
March 20, 2015
Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated May 6, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, RBC Capital Markets, LLC and Deutsche Bank Securities Inc., relating to the 7.25% Senior Notes due 2022, to be bound by the terms and provisions of such Registration Rights Agreement.




Exhibit 10.245


IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.



APHRODITE WOMEN’S HEALTH, LLC
as a Guaranteeing Subsidiary
 
 
By:
AMERICAN MEDICAL SYSTEMS
 
HOLDINGS, INC., its manager
By:
/s/ Deanna Voss
Name:
 Deanna Voss 
Title:
 Assistant Secretary

ENDO VENTURES CYPRUS LIMITED
as a Guaranteeing Subsidiary
By:
/s/ Orla Dunlea
Name:
Orla Dunlea
Title:
Director


[Signature Page to Registration Rights Agreement Counterpart - 7.25% Senior Notes due 2022]